Top Glove Corporation Bhd

Top Glove Corporation Bhd

Health CareHealth Care Equipment & Services
  • Price (MYR)6.59
  • Today's Change0.19 / 2.97%
  • Shares traded6.54m
  • 1 Year change32.60%
  • Beta--
Data delayed at least 15 minutes, as of Oct 20 2017.
More ▼

Events & Activity

  • TOPGLOV:KLS price reached a new 52-week high of 6.65 at 13:29 BST
  • TOPGLOV:KLS price reached a new 52-week high of 6.46 at 10:44 BST
  • TOPGLOV:KLS trading volume exceeds daily average by +113.09%
  • TOPGLOV:KLS price reached a new 52-week high of 6.30 at 13:29 BST
  • TOPGLOV:KLS price moved over +4.83% to 6.30

Key statistics

Top Glove Corporation Bhd (TOPGLOV:KLS) set a new 52-week high during Friday's trading session when it reached 6.80. Over this period, the share price is up 32.60%.
52-week range
4.56Apr 28 20176.80Oct 20 2017
Markit short selling activity
Previous close6.40
Average volume5.44m
Shares outstanding1.26bn
Free float738.37m
P/E (TTM)24.85
Market cap8.28bn MYR
EPS (TTM)0.2652
Annual div (ADY)0.145
Annual div yield (ADY)2.27%
Div ex-dateJul 03 2017
Div pay-dateJul 17 2017
Data delayed at least 15 minutes, as of Oct 20 2017.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.